Pharmacokinetic Evaluation of Twice-Daily Extended-Release Carbamazepine(CBZ) and Four-Times-Daily Immediate-Release CBZ in Patients with Epilepsy
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-03-01
著者
-
Pellock John
Department Of Neurology And The Comprehensive Epilepsy Institute Medical College Of Virginia Of Virg
-
Pellock John
Department Of Neurology Virginia Commonwealth University Medical College Of Virginia
-
Mclean Angus
Shire Laboratories (formerly Pharmavene)
-
GARNETT William
Department of Pharmacy and Pharmaceutics Virginia Commonwealth University Medical College of Virgini
-
LEVY Benjamin
Scirex (formerly) National Medical Research Corporation
-
ZHANG Yuxin
Shire Laboratories (formerly Pharmavene)
-
COUCH Richard
Shire Laboratories (formerly Pharmavene)
-
RUDNIC Edward
Shire Laboratories (formerly Pharmavene)
-
BELENDIUK George
Shire Laboratories (formerly Pharmavene)
-
Garnett William
Department Of Pharmacy And Pharmaceutics Virginia Commonwealth University Medical College Of Virgini
関連論文
- Short-Term Outcomes of Children with Febrile Status Epilepticus
- In Whom Does Status Epilepticus Occur: Age-Related Differences in Children
- Pharmacokinetic Evaluation of Twice-Daily Extended-Release Carbamazepine(CBZ) and Four-Times-Daily Immediate-Release CBZ in Patients with Epilepsy
- Lamotrigine-Associated Rash : Risk/Benefit Considerations in Adults and Children
- Felbamate
- Clinical Pharmacology of Topiramate: A Review
- The Challenge of Treatment Selection for Epilepsy
- Status Epilepticus in a Population-based Virginia Twin Sample